National Breast Cancer Coalition

Vera Bradley Foundation for Breast Cancer Classic Event Raises $1,127,000 for Breast Cancer Research

Retrieved on: 
Tuesday, September 20, 2022
Indiana University School of Medicine, Volunteering, Woman, Classic, Center, Research, Breast cancer, National, Breast Cancer Awareness Month, National Breast Cancer Coalition, Facebook, Technology, Instagram, Foundation, Diagnosis, Roswell Park Comprehensive Cancer Center, GLOBE, National Cancer Institute, School, Disease, Pharmaceutical industry, Dietary supplement, Birth control, Medicine

FORT WAYNE, Ind., Sept. 19, 2022 (GLOBE NEWSWIRE) -- The Vera Bradley Foundation for Breast Cancer (the "Foundation") today announced its 2022 Vera Bradley Foundation for Breast Cancer Classic fundraiser (the Classic) raised $1,127,000 to support the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine (IU School of Medicine).

Key Points: 
  • FORT WAYNE, Ind., Sept. 19, 2022 (GLOBE NEWSWIRE) -- The Vera Bradley Foundation for Breast Cancer (the "Foundation") today announced its 2022 Vera Bradley Foundation for Breast Cancer Classic fundraiser (the Classic) raised $1,127,000 to support the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine (IU School of Medicine).
  • The Foundations ongoing support led to the 2018 creation of the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center (the IU Cancer Center) where more than 30 investigators collaborate on breast cancer discoveries.
  • Thank you to every sponsor, participant, volunteer, and guest who made the 2022 Vera Bradley Foundation for Breast Cancer Classic a success.
  • The Vera Bradley Foundation for Breast Cancer raises funds for breast cancer research to find a cure and to improve the lives of the many affected by this disease.

Susan G. Komen® MORE THAN PINK Walk Raises Money for Health Equity Initiatives in the Miami/Ft. Lauderdale Area

Retrieved on: 
Thursday, September 8, 2022
Theta, University, Breast cancer, Health equity, Delta Sigma, National Breast Cancer Coalition, Amelia Earhart Park, Komen, Walking, Bank of America, State, THAN, Breast Cancer Awareness Month, Susan, Bank, Patient, Birth control, Genentech, Walgreens

MIAMI, Sept. 8, 2022 /PRNewswire/ -- Susan G. Komen , the world's leading breast cancer organization, will hold an in-person MORE THAN PINK Walk to raise critical funds that support breast cancer patients and support Komen's health equity initiatives in the Miami area and beyond.

Key Points: 
  • MIAMI, Sept. 8, 2022 /PRNewswire/ -- Susan G. Komen , the world's leading breast cancer organization, will hold an in-person MORE THAN PINK Walk to raise critical funds that support breast cancer patients and support Komen's health equity initiatives in the Miami area and beyond.
  • The Walk will be held on October 8, 2022, at Amelia Earhart Park.
  • "We look forward to creating a community for anyone impacted by breast cancer as we gather, in person, for this year's Walk.
  • A portion of the proceeds from select businesses in the area will go toward Komen's mission to end breast cancer forever.

Susan G. Komen® Announces The Return Of MORE THAN PINK Walk, Race for the Cure And Walk Where You Are Across The U.S.

Retrieved on: 
Monday, July 11, 2022
Family, City, Survivor, CEO, Hope, Disease, Breast cancer, Education, Policy, Bank, National Breast Cancer Coalition, Cure, Friends, Strathcona County, THAN, Research, Patient, Race, Bank of America, Walking, Online gambling, Toy, Birth control, Entertainment, Dietary supplement, Instrumentation, Walgreens

DALLAS, July 11, 2022 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, has announced the return of its annual Susan G. Komen MORE THAN PINK Walk and Race for the Cure in 40 cities across the U.S. and the virtual Walk Where You Are event. 

Key Points: 
  • Susan G. Komen's annual MORE THAN PINK Walk and Race for the Cure series will return in 40 cities across the U.S.
  • For many of the cities, this will be the first in-person race or walk since 2019.
  • Participants of the MORE THAN PINK Walk or Race for the Cure include breast cancer survivors, co-survivors, individuals living with metastatic breast cancer, friends, family and other supporters.
  • Bank of America and Walgreens are national sponsors for the MORE THAN PINK Walk, Race for the Cure and Walk Where You Are.

BREAST CANCER ADVOCATES TO CONGRESS: ACT NOW TO ALLEVIATE OUR HARDSHIPS

Retrieved on: 
Wednesday, April 27, 2022
Metastatic breast cancer, Undue hardship, Social, Breast cancer, Investor, National Breast Cancer Coalition, Prognosis, Social Security Disability Insurance, Woman, Google Images, Legislation, Research, Toxicity, Diagnosis, Social Security, Komen, Hospital Insurance and Diagnostic Services Act, Policy advocacy, MBC, Capitol Hill, Senate, Program, Patient, Care, Finance, Electoral History of the Conservative Party of New York State (U.S. House Results), Survivor, Breast, Biopsy, Ill, Man, Color, Statistics, Access, Public health, Disease, House, Susan, Medicare, Cancer, Congress, Birth control, Medical imaging, Health insurance, Policy

DALLAS, April 27, 2022 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, today called on Congress to prioritize three bills that would provide immediate relief to people impacted by breast cancer. There are more than 3.8 million breast cancer survivors or people living with breast cancer in the U.S. Additionally, more than 290,000 women and men in the U.S. will be diagnosed with invasive breast cancer in 2022 alone. Breast cancer is the most common cancer found in women in the U.S. and the second leading cause of cancer death in women.

Key Points: 
  • There are more than 3.8 million breast cancer survivors or people living with breast cancer in the U.S. Additionally, more than 290,000 women and men in the U.S. will be diagnosed with invasive breast cancer in 2022 alone.
  • Breast cancer is the most common cancer found in women in the U.S. and the second leading cause of cancer death in women.
  • When an abnormality is detected in the breast, diagnostic imaging is needed to rule out breast cancer or confirm the need for a biopsy.
  • Susan G. Komen is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever.

Global Colposcopy Market Size, Share & Trends Analysis 2022-2030 by Modality (Optical, Video), Application (Pelvic, Oral), Portability (Handheld, Stationary) - ResearchAndMarkets.com

Retrieved on: 
Monday, April 4, 2022
General Health, Health, Oncology, Adoption, CAGR, USD, National Breast Cancer Coalition, Diagnosis, Marketing, Hospital Insurance and Diagnostic Services Act, HPV, Breast, Woman, Ageing, Cancer, Death, Prevalence, Cervical cancer, COVID-19, Mobile device, Colposcopy, Awareness, Disease, Optics, Birth control, Healthcare

The "Colposcopy Market Size, Share & Trends Analysis Report by Modality (Optical, Video), by Application (Pelvic, Oral), by Portability (Handheld, Stationary), by End-use, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Colposcopy Market Size, Share & Trends Analysis Report by Modality (Optical, Video), by Application (Pelvic, Oral), by Portability (Handheld, Stationary), by End-use, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global colposcopy market size is expected to reach USD 761.2 million by 2030 and is expected to expand at a CAGR of 4.8% from 2022 to 2030.
  • Increase in the prevalence of cervical cancer, technological advancements, and the rising demand for early- diagnosis of gynecological disorders are expected to boost the market growth.
  • The video colposcopy segment is expected to grow at the fastest rate during the forecast period.

Karmanos Cancer Institute Celebrates 50th Anniversary of the National Cancer Act

Retrieved on: 
Tuesday, February 1, 2022
Disease, NCA, CEO, Legislation, YouTube, Patient, Karmanos Cancer Institute, CAR, Institute, Hospital, Mortality, Communication, McLaren Health Care Corporation, University School, Clinical trial, National, National Cancer Institute, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Metro Detroit, Wayne State University School of Medicine, Strathcona County, Twitter, LLC, Technology, United States Public Health Service, Woman, Research, Death, PCP, President's Cancer Panel, Cancer, Partnership, Interview, Immortalised cell line, Incidence, National Breast Cancer Coalition, Courage, Education, News, NCI, War on cancer, Wayne, FDA, Mouse, Breast cancer, LinkedIn, Multimedia, Public Health Service Act, Dietary supplement, Pharmaceutical industry, Vaccine, Facebook, Medicine

DETROIT, Feb. 01, 2022 /PRNewswire/ --The Barbara Ann Karmanos Cancer Institute, along with hospitals, researchers, advocates and policymakers across the country, recognizes the 50th Anniversary of the National Cancer Act (NCA).

Key Points: 
  • DETROIT, Feb. 01, 2022 /PRNewswire/ --The Barbara Ann Karmanos Cancer Institute, along with hospitals, researchers, advocates and policymakers across the country, recognizes the 50th Anniversary of the National Cancer Act (NCA).
  • The National Cancer Act established the current iteration of the National Cancer Institute (NCI) and enabled the development of a national cancer program.
  • "The National Cancer Act was a game-changer for cancer treatment and research," said Gerold Bepler, M.D., Ph.D., President and CEO of Karmanos Cancer Institute .
  • In 1978, just seven years after its inception, the National Cancer Institute (NCI) designated Karmanos Cancer Institute as a comprehensive cancer center.

NACDD Hires Senior Director of Health Equity, Celebrates Achievements Advancing Anti-Racism in State Health

Retrieved on: 
Monday, January 31, 2022
Steps, Guideline, Health equity, Policy, National Association, Goal, Chronic condition, Challenge, Association, MPH, MBA, Terminology, National Breast Cancer Coalition, Management, Medical device

Robyn Taylor, MBA, has been hired to serve as the Senior Director of Health Equity.

Key Points: 
  • Robyn Taylor, MBA, has been hired to serve as the Senior Director of Health Equity.
  • NACDD also announces several other achievements in the Association's work to promote Health Equity given the continued widening health disparities among historically marginalized and oppressed communities.
  • "Robyn has done significant work for the Association as our Health Equity consultant and as a leader in our Health Equity Council ," said NACDD CEO John W. Robitscher, MPH.
  • In the new role, Taylor also will lead the development of a center for health equity at NACDD.

XPO Logistics Trucks and Drivers to Support Susan G. Komen 3-Day® Walks as Official Transportation Partner through 2022

Retrieved on: 
Friday, October 15, 2021
Instagram, XPO, LinkedIn, Awareness, Breast cancer, XPO Logistics, Breast Cancer Awareness Month, Transport, YouTube, NYSE, Disease, Patient, National Breast Cancer Coalition, GLOBE, LTL, Family, Twitter, Partnership, Cure, COVID-19, Management, Pharmaceutical industry

In addition, the company will continue to provide storage for Komen equipment, supplies and merchandise between events.

Key Points: 
  • In addition, the company will continue to provide storage for Komen equipment, supplies and merchandise between events.
  • Josephine Berisha, chief human resources officer for XPO Logistics, said, Were proud to stand with Susan G. Komen in working toward a cure for breast cancer.
  • XPO Logistics, Inc. (NYSE: XPO) is a leading provider of freight transportation services, primarily truck brokerage and less-than-truckload (LTL).
  • Susan G. Komen is the worlds leading nonprofit breast cancer organization, working to save lives and end breast cancer forever.

Advancements in reproductive medicine available at Shady Grove Fertility (SGF) can reduce the inheritance of genetic diseases like breast cancer

Retrieved on: 
Thursday, October 14, 2021
Genetic testing, K Street, Miss, Wiskott–Aldrich syndrome, Miss America, Breast cancer, Awareness, ASRM, Risk, Cancer, Fertility, Physician, Corporation, Degenerative disease, Child, Population, Infertility, Woman, Insurance, Cystic fibrosis, Education, Miss USA, SGF, Fertility preservation, Disease, Genetic counseling, Patient, National Breast Cancer Coalition, Tay–Sachs disease, IVF, PGT, Allyn, Rose, Directorate of Research and Civil Affairs, Partnership, Hope, Cancer survivor, Sex linkage, Vaccine, Birth control, Animal, Pharmaceutical industry

Individuals and couples with known genetic diseases can turn to Shady Grove Fertility (SGF) to undergo in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects(PGT-M) to reduce the risk of passing genetic mutations to future offspring.

Key Points: 
  • Individuals and couples with known genetic diseases can turn to Shady Grove Fertility (SGF) to undergo in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects(PGT-M) to reduce the risk of passing genetic mutations to future offspring.
  • Additionally, patients at risk for dominant gene mutations, such as breast cancer or inherited forms of colon cancer, can have individualized testing for these diseases.
  • While Rose is not a carrier for the breast cancer gene, she is a carrier of a rare X-linked genetic mutation called Wiskott-Aldrich syndrome.
  • We are so fortunate to live in a world where we can now reduce the inheritance of deadly genetic diseases via IVF.

Shares for the Cure: Simplify Introduces Health Care ETF Benefiting Susan G. Komen

Retrieved on: 
Friday, October 8, 2021
Biotechnology, Finance, Health, Professional Services, Oncology, Prospectus, ETF, Patent, Risk, Exchange-traded fund, LLC, Biotechnology, Breast cancer, Food, Mortality, CFA, Cancer, Industry, National Breast Cancer Coalition, Breast Cancer Awareness Month, Investment, Entrepreneurship, Fund, Criticism of the Food and Drug Administration, Woman, CEO, Regulation, Disease, Patient, Government, Research, Simplification, Insurance, PINK, Pharmaceutical industry, Financial services, Bank

Simplify Asset Management (Simplify) , an innovative provider of Exchange Traded Funds (ETFs), today announced the launch of the Simplify Health Care ETF (PINK) , the first ETF committed to donating all of its net profits from managing the fund on an annual basis to Susan G. Komen, the worlds leading breast cancer organization.

Key Points: 
  • Simplify Asset Management (Simplify) , an innovative provider of Exchange Traded Funds (ETFs), today announced the launch of the Simplify Health Care ETF (PINK) , the first ETF committed to donating all of its net profits from managing the fund on an annual basis to Susan G. Komen, the worlds leading breast cancer organization.
  • This commitment will help support our advocacy, breakthrough research and important patient support and care for those facing the disease today.
  • I could not be more pleased to be working with the Simplify team on PINK, providing investors with an important new tool while supporting the crucial work of Susan G. Komen.
  • Susan G. Komen is the worlds leading nonprofit breast cancer organization, working to save lives and end breast cancer forever.